These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8761307)

  • 1. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M; Rong S; Anver M; Vande Woude GF
    Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
    Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
    Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.
    Zhang YW; Wang LM; Jove R; Vande Woude GF
    Oncogene; 2002 Jan; 21(2):217-26. PubMed ID: 11803465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
    Yang XM; Park M
    Lab Invest; 1995 Oct; 73(4):483-91. PubMed ID: 7474919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G
    J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW; Vande Woude GF
    J Cell Biochem; 2003 Feb; 88(2):408-17. PubMed ID: 12520544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.
    Firon M; Shaharabany M; Altstock RT; Horev J; Abramovici A; Resau JH; Vande Woude GF; Tsarfaty I
    Oncogene; 2000 May; 19(20):2386-97. PubMed ID: 10828880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
    Yu Y; Merlino G
    Cancer Res; 2002 May; 62(10):2951-6. PubMed ID: 12019177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
    Zhu H; Naujokas MA; Park M
    Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Met expression and sarcoma tumorigenicity.
    Rong S; Jeffers M; Resau JH; Tsarfaty I; Oskarsson M; Vande Woude GF
    Cancer Res; 1993 Nov; 53(22):5355-60. PubMed ID: 7693339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.
    Gherardi E; Sharpe M; Lane K; Sirulnik A; Stoker M
    Symp Soc Exp Biol; 1993; 47():163-81. PubMed ID: 8165564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
    Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.